Skip to main content

Loading market ticker...

Hester Biosciences

Healthcare NSE:HESTERBIO

2237.90INR
70.90 ( 3.27%)

Last update at July 3, 2026, 10:14 a.m.

Day Range

2167.002295.00
LowHigh

52 Week Range

1238.65 2350.75
LowHigh

Fundamentals

  • Previous Close 2167.00
  • Market Cap 13525.06M
  • Volume6,022
  • P/E Ratio 31.25
  • EBITDA 687.39M
  • Revenue TTM 3105.67M
  • Revenue Per Share TTM 354.27
  • Gross Profit TTM 2239.05M
  • Diluted EPS TTM 50.88

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 395.71M 319.53M 401.54M 535.02M 501.03M
Net income 274.88M 188.89M 266.27M 393.20M 344.30M
Total Revenue 3111.02M 3045.46M 2660.91M 2350.06M 2143.32M
Gross Profit 2084.73M 972.64M 1886.05M 1661.51M 1579.39M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 6533.85M 6623.47M 5458.15M 5621.61M 4110.49M
Intangible assets 66.57M 39.32M 28.40M 20.45M 4.21M
Other current assets 443.97M 450.85M 260.17M 0.95M 10.40M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -67.83M -4.08M -115.94M 34.81M -22.62M
Operating Cash 645.11M 481.34M 235.96M 88.08M 580.53M
Free Cash Flow 439.20M 237.37M -541.66M -869.02M 173.11M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
HESTERBIO
Hester Biosciences 		70.90 3.27% 2237.90 13525.06 31.25
SUNPHARMA
Sun Pharmaceutical Industries Limited 		39.00 2.08% 1910.00 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		84.50 1.26% 6767.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		64.50 1.38% 4725.90 1362716.66 63.48
CIPLA
Cipla Limited 		5.00 0.34% 1461.00 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.